← Back to news
Y

Yahoo Finance

Why Monday.com Stock Sank In 2025

Y

China May Be Blocking H200 Shipments After All. Should You Sell the News for Nvidia Stock?

Y

Rigetti and Quantum Computing Stocks Are a Buy, Says Analyst. Look Past the Criticism of Both.

Y

Silver Falls After Trump Holds Off on Critical Mineral Tariffs

Y

Here’s What Analysts Think About Banco Bilbao Vizcaya Argentaria (BBVA)

Y

What Does Wall Street Think About Banco Santander (SAN)?

Y

Why is Equinor ASA (EQNR) One of the Best Affordable Stocks Under $30?

Y

Piper Believes Stellantis N.V. (STLA) Has the Potential for “Rapid Upside” – Here’s Why

Y

Barclays Maintains Overweight Rating on Energy Transfer LP (ET)

Y

Where is Vale S.A. (VALE) Headed According to Analysts?

Y

This is What Analysts Are Saying About Cenovus Energy Inc. (CVE)

Y

Where is JD.com (JD) Headed According to the Street?

Y

Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30

Y

2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run

Y

Here is What Analysts Think About AT&T Inc. (T)

Y

Here’s What Analysts Think About Fortinet (FTNT)

Y

What Do Analysts Think About KLA Corporation (KLAC)?

Y

Where is Palantir Technologies Inc. (PLTR) Headed According to Analysts?

Y

This is What Analysts Think About Arista Networks (ANET)

Y

What Does Wall Street Think About ServiceNow (NOW)?

Y

Where is Eli Lilly and Company (LLY) Headed According to Analysts?

Y

Is Advanced Micro Devices (AMD) One of the Best Long Term Growth Stocks to Buy According to Hedge Funds?

Y

This is What The Street Thinks About Uber Technologies (UBER)

Y

OpenAI Seeks US-Based Suppliers for Planned Robotics, AI Device Push

Y

What's Driving This Week's Market Swings? It Could Be Inflation.

Y

Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook

Y

Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)

Y

Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why

Y

Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026

Y

Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

Y

Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept

Y

Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral

Y

Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now?

Y

Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus

Y

Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating

Y

Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib

Y

HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating

Y

Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN)

Y

Senate Dems To Discuss Clarity Act Concerns With Crypto Representatives

Y

Silver Prices Keep Confounding Experts. I Won’t Be Surprised If They Hit $100 Soon.

Y

Silver surge masks quiet risk

Y

MrBeast Eyes DeFi as Tom Lee's Ethereum Treasury BitMine Invests $200 Million

Y

I Was Right About Interest Rates in 2025. Here's What I Think Will Happen in 2026.

Y

3 Technology Stocks to Sell in 2026

Y

Jamie Dimon’s High-Wire Act Runs Into Trouble

Y

Noodles & Company is closing 30 more restaurants: List of doomed locations grows in 2026

Y

2 Cheap Mid-Cap Growth Stocks That Can Benefit From Lower Interest Rates

Y

Labor, tariffs collide with data center boom

Y

Aramark Told to Sell Entier by U.K. Merger Watchdog

Y

CME Group to Launch Cardano, Chainlink, Stellar Futures on Feb 9

Y